US5145684A
(en)
*
|
1991-01-25 |
1992-09-08 |
Sterling Drug Inc. |
Surface modified drug nanoparticles
|
US5399363A
(en)
*
|
1991-01-25 |
1995-03-21 |
Eastman Kodak Company |
Surface modified anticancer nanoparticles
|
FR2684298B1
(fr)
*
|
1991-12-03 |
1994-03-11 |
Rhone Poulenc Rorer Sa |
Nouvelles compositions pharmaceutiques solides a base de derives de lapiperidine substitues en 1,4.
|
US5302400A
(en)
*
|
1992-06-22 |
1994-04-12 |
Digestive Care Inc. |
Preparation of gastric acid-resistant microspheres containing digestive enzymes and buffered-bile acids
|
US7336788B1
(en)
*
|
1992-12-09 |
2008-02-26 |
Discovery Communicatoins Inc. |
Electronic book secure communication with home subsystem
|
DE69324504T2
(de)
*
|
1993-01-19 |
1999-08-26 |
Warner Lambert Co |
Stabilisierte, oral anzuwendende zusammensetzung enthaltend die verbindung ci-981 und verfahren
|
US20070117863A1
(en)
*
|
1993-02-22 |
2007-05-24 |
Desai Neil P |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
IS1796B
(is)
*
|
1993-06-24 |
2001-12-31 |
Ab Astra |
Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband
|
US6632456B1
(en)
|
1993-06-24 |
2003-10-14 |
Astrazeneca Ab |
Compositions for inhalation
|
US6794357B1
(en)
|
1993-06-24 |
2004-09-21 |
Astrazeneca Ab |
Compositions for inhalation
|
US5747445A
(en)
*
|
1993-06-24 |
1998-05-05 |
Astra Aktiebolag |
Therapeutic preparation for inhalation
|
US20010003739A1
(en)
*
|
1993-06-24 |
2001-06-14 |
Astrazeneca Ab |
Systemic administration of a therapeutic preparation
|
US5830853A
(en)
*
|
1994-06-23 |
1998-11-03 |
Astra Aktiebolag |
Systemic administration of a therapeutic preparation
|
TW402506B
(en)
*
|
1993-06-24 |
2000-08-21 |
Astra Ab |
Therapeutic preparation for inhalation
|
US7865567B1
(en)
|
1993-12-02 |
2011-01-04 |
Discovery Patent Holdings, Llc |
Virtual on-demand electronic book
|
US6165976A
(en)
*
|
1994-06-23 |
2000-12-26 |
Astra Aktiebolag |
Therapeutic preparation for inhalation
|
CA2172807C
(en)
*
|
1994-08-01 |
1999-10-12 |
Keith S. Lienhop |
Tastemasked liquid pharmaceutical delivery system
|
US5618845A
(en)
|
1994-10-06 |
1997-04-08 |
Cephalon, Inc. |
Acetamide derivative having defined particle size
|
MX9704550A
(es)
|
1994-12-22 |
1997-10-31 |
Astra Ab |
Formulaciones de medicamentos en aerosol.
|
EP0806945B1
(de)
|
1994-12-22 |
2003-04-23 |
AstraZeneca AB |
Parathyroidhormon pth enthaltende therapeutische zubereitung zur inhalation
|
SE9404468D0
(sv)
*
|
1994-12-22 |
1994-12-22 |
Astra Ab |
Powder formulations
|
US6524557B1
(en)
|
1994-12-22 |
2003-02-25 |
Astrazeneca Ab |
Aerosol formulations of peptides and proteins
|
US5503723A
(en)
*
|
1995-02-08 |
1996-04-02 |
Eastman Kodak Company |
Isolation of ultra small particles
|
US6458811B1
(en)
*
|
1996-03-26 |
2002-10-01 |
Eli Lilly And Company |
Benzothiophenes formulations containing same and methods
|
US5750104A
(en)
*
|
1996-05-29 |
1998-05-12 |
Digestive Care Inc. |
High buffer-containing enteric coating digestive enzyme bile acid compositions and method of treating digestive disorders therewith
|
CN100462066C
(zh)
*
|
1997-06-27 |
2009-02-18 |
美国生物科学有限公司 |
药剂的新制剂及其制备和应用方法
|
ZA991922B
(en)
|
1998-03-11 |
1999-09-13 |
Smithkline Beecham Corp |
Novel compositions of eprosartan.
|
US6197347B1
(en)
|
1998-06-29 |
2001-03-06 |
Andrx Pharmaceuticals, Inc. |
Oral dosage for the controlled release of analgesic
|
US7521068B2
(en)
|
1998-11-12 |
2009-04-21 |
Elan Pharma International Ltd. |
Dry powder aerosols of nanoparticulate drugs
|
US6432448B1
(en)
*
|
1999-02-08 |
2002-08-13 |
Fmc Corporation |
Edible coating composition
|
EG23951A
(en)
|
1999-03-25 |
2008-01-29 |
Otsuka Pharma Co Ltd |
Cilostazol preparation
|
US6787531B1
(en)
*
|
1999-08-31 |
2004-09-07 |
Schering Ag |
Pharmaceutical composition for use as a contraceptive
|
US6500462B1
(en)
*
|
1999-10-29 |
2002-12-31 |
Fmc Corporation |
Edible MCC/PGA coating composition
|
ES2240222T3
(es)
|
1999-12-20 |
2005-10-16 |
Nicholas J. Kerkhof |
Procedimiento para producir particulas nanometricas mediante secado por pulverizacion en lecho fluidizado.
|
US8771740B2
(en)
|
1999-12-20 |
2014-07-08 |
Nicholas J. Kerkhof |
Process for producing nanoparticles by spray drying
|
IL154457A0
(en)
*
|
2000-08-14 |
2003-09-17 |
Teva Pharma |
Mircronized torsemide
|
TR200300731T2
(tr)
|
2000-11-28 |
2004-08-23 |
Fmc Corporation |
Yenebilir PGA kaplama bileşimi
|
US6932861B2
(en)
*
|
2000-11-28 |
2005-08-23 |
Fmc Corporation |
Edible PGA coating composition
|
US6544552B2
(en)
|
2001-01-11 |
2003-04-08 |
Particle And Coating Technologies, Inc. |
Method of producing porous tablets with improved dissolution properties
|
WO2002069977A1
(en)
|
2001-03-01 |
2002-09-12 |
Hollis-Eden Pharmaceuticals, Inc. |
Use of certain steroids for treatment of blood cell deficiencies
|
ATE301499T1
(de)
*
|
2001-06-29 |
2005-08-15 |
Eurand Pharmaceuticals Ltd |
Verfahren zur arzneimittelaktivierung mittels schwingmühle
|
WO2007064311A1
(en)
*
|
2001-07-10 |
2007-06-07 |
Teva Pharmaceutical Industries Ltd. |
Micronized mirtazapine
|
EP1423175B1
(de)
*
|
2001-08-08 |
2013-10-02 |
Brown University Research Foundation |
Verfahren zur mikronisierung von hydrophoben arzneistoffen
|
US7217426B1
(en)
|
2002-06-21 |
2007-05-15 |
Advanced Cardiovascular Systems, Inc. |
Coatings containing polycationic peptides for cardiovascular therapy
|
US7033602B1
(en)
|
2002-06-21 |
2006-04-25 |
Advanced Cardiovascular Systems, Inc. |
Polycationic peptide coatings and methods of coating implantable medical devices
|
US6994867B1
(en)
|
2002-06-21 |
2006-02-07 |
Advanced Cardiovascular Systems, Inc. |
Biocompatible carrier containing L-arginine
|
US7011842B1
(en)
|
2002-06-21 |
2006-03-14 |
Advanced Cardiovascular Systems, Inc. |
Polycationic peptide coatings and methods of making the same
|
US8506617B1
(en)
|
2002-06-21 |
2013-08-13 |
Advanced Cardiovascular Systems, Inc. |
Micronized peptide coated stent
|
US7056523B1
(en)
|
2002-06-21 |
2006-06-06 |
Advanced Cardiovascular Systems, Inc. |
Implantable medical devices incorporating chemically conjugated polymers and oligomers of L-arginine
|
US7794743B2
(en)
*
|
2002-06-21 |
2010-09-14 |
Advanced Cardiovascular Systems, Inc. |
Polycationic peptide coatings and methods of making the same
|
US7070798B1
(en)
|
2002-06-21 |
2006-07-04 |
Advanced Cardiovascular Systems, Inc. |
Coatings for implantable medical devices incorporating chemically-bound polymers and oligomers of L-arginine
|
US20040048931A1
(en)
*
|
2002-07-12 |
2004-03-11 |
Craig Heacock |
Modafinil pharmaceutical compositions
|
US7094256B1
(en)
|
2002-12-16 |
2006-08-22 |
Advanced Cardiovascular Systems, Inc. |
Coatings for implantable medical device containing polycationic peptides
|
US20040121003A1
(en)
*
|
2002-12-19 |
2004-06-24 |
Acusphere, Inc. |
Methods for making pharmaceutical formulations comprising deagglomerated microparticles
|
US20040146537A1
(en)
*
|
2003-01-28 |
2004-07-29 |
Ramachandran Radhakrishnan |
Oily wax matrix suspension formulation comprising pharmacologically active agents
|
WO2004075841A2
(en)
*
|
2003-02-24 |
2004-09-10 |
Mallinckrodt Inc. |
Process for preparing benzhydrylthioacetamide
|
US20040253308A1
(en)
*
|
2003-04-29 |
2004-12-16 |
Barr Laboratories, Inc. |
Surface-treated modafinil particles
|
BRPI0412523A
(pt)
*
|
2003-07-11 |
2006-09-19 |
Hoffmann La Roche |
forma de dosagem oral de mesilato de saquinavir
|
MXPA06000524A
(es)
*
|
2003-07-18 |
2006-08-11 |
Santarus Inc |
Formulacion farmaceutica y metodo para tratar desordenes gastrointestinales provocados por acido.
|
CN1878602A
(zh)
*
|
2003-11-28 |
2006-12-13 |
三菱化学株式会社 |
有机化合物微粒的制造方法
|
BRPI0418373A
(pt)
*
|
2004-01-08 |
2007-05-22 |
Wyeth Corp |
composição farmacêutica, unidade de dosagem de cci-779 oral, método de fornecimento de cci-779 a um paciente, e, uso de cci-779 micronizado
|
EP1807118B8
(de)
|
2004-09-29 |
2014-04-23 |
Harbor Therapeutics, Inc. |
Steroidanaloga sowie charakterisierungs- und behandlungsverfahren
|
ES2231043B2
(es)
*
|
2004-10-29 |
2005-10-01 |
Laboratorios Cinfa, S.A. |
Composicion farmaceutica de ebastina de liberacion inmediata y su proceso de fabricacion.
|
JP4754211B2
(ja)
*
|
2004-12-28 |
2011-08-24 |
ライオン株式会社 |
粒状医薬組成物及びその製造方法
|
CA2858733C
(en)
*
|
2004-12-31 |
2017-12-19 |
Iceutica Pty Ltd |
Nanoparticle compositions and methods for synthesis thereof
|
ES2371414T3
(es)
*
|
2005-07-25 |
2012-01-02 |
Otsuka Pharmaceutical Co., Ltd. |
Preparación oral para medir la capacidad metabólica de la pirimidina.
|
MX2008001532A
(es)
*
|
2005-08-02 |
2008-04-22 |
Drossapharm Ag |
Composicion farmaceutica que contiene indometacina y/o acemetacina.
|
US20070092576A1
(en)
*
|
2005-10-20 |
2007-04-26 |
Adolor Corporation |
Compositions containing opioid antagonists
|
WO2007070843A2
(en)
*
|
2005-12-15 |
2007-06-21 |
Acusphere, Inc. |
Processes for making particle-based pharmaceutical formulations for oral administration
|
EP1973523A2
(de)
*
|
2005-12-15 |
2008-10-01 |
Acusphere, Inc. |
Verfahren zur herstellung von pharmazeutischen formulierungen auf teilchenbasis zur pulmonalen oder nasalen verabreichung
|
EP1849459A1
(de)
*
|
2006-03-06 |
2007-10-31 |
Teva Pharmaceutical Industries Ltd. |
Ezetimibzusammensetzungen
|
JP2007314529A
(ja)
*
|
2006-04-28 |
2007-12-06 |
Lion Corp |
造粒粒子、錠剤、及び造粒粒子の製造方法
|
AU2007264418B2
(en)
*
|
2006-06-30 |
2012-05-03 |
Iceutica Pty Ltd |
Methods for the preparation of biologically active compounds in nanoparticulate form
|
AU2012203877B2
(en)
*
|
2006-06-30 |
2013-10-10 |
Iceutica Pty Ltd |
Methods For The Preparation Of Biologically Active Compounds In Nanoparticulate Form
|
AU2013273795C1
(en)
*
|
2006-06-30 |
2016-08-18 |
Iceutica Pty Ltd |
Method for the Preparation of Biologically Active Compounds in Nanoparticle Form
|
AU2016203251B2
(en)
*
|
2006-06-30 |
2017-11-16 |
Iceutica Pty Ltd |
Methods for the Preparation of Biologically Active Compounds in Nanoparticle Form
|
NZ599069A
(en)
*
|
2006-06-30 |
2013-10-25 |
Iceutica Pty Ltd |
Methods for the Preparation of Biologically Active Compounds in Nanoparticulate Form
|
US20080181966A1
(en)
*
|
2006-10-18 |
2008-07-31 |
Cephalon, Inc. |
Modafinil pharmaceutical compositions
|
MY149356A
(en)
*
|
2007-03-29 |
2013-08-30 |
Daiichi Sankyo Co Ltd |
Pharmaceutical composition
|
TWI405590B
(zh)
|
2007-04-06 |
2013-08-21 |
Activus Pharma Co Ltd |
微粉碎化有機化合物粒子之製法
|
EP2146695A4
(de)
*
|
2007-04-23 |
2010-05-19 |
Sun Pharmaceuticals Ind Ltd |
Pharmazeutische zusammensetzungen
|
JP2009091298A
(ja)
*
|
2007-10-10 |
2009-04-30 |
Asuka Corporation:Kk |
皮膚改善化粧料
|
CA2714112C
(en)
*
|
2008-02-06 |
2015-08-11 |
Wockhardt Research Centre |
Pharmaceutical compositions of entacapone, levodopa and carbidopa with improved bioavailability
|
BRPI0907727A2
(pt)
*
|
2008-02-06 |
2017-06-13 |
Wockhardt Res Centre |
composições farmacêuticas de entacapone co-micronizado com alcoóis de açúcar
|
US20170105966A1
(en)
*
|
2008-02-28 |
2017-04-20 |
Roger Imboden |
Pharmaceutical composition containing indometacin and/or acemetacin
|
PT2273994E
(pt)
|
2008-04-03 |
2016-03-15 |
Neurmedix Inc |
Formas de estado sólido de um produto farmacêutico
|
JP5149673B2
(ja)
*
|
2008-04-03 |
2013-02-20 |
有限会社不動権現 |
こんにゃく粉製造方法
|
US20100016450A1
(en)
*
|
2008-07-21 |
2010-01-21 |
Otonomy, Inc. |
Controlled release delivery devices for the treatment of otic disorders
|
DE102008037025C5
(de)
*
|
2008-08-08 |
2016-07-07 |
Jesalis Pharma Gmbh |
Verfahren zur Herstellung kristalliner Wirkstoff-Mikropartikel bzw. einer Wirkstoffpartikel-Festkörperform
|
JP5536654B2
(ja)
*
|
2008-09-19 |
2014-07-02 |
株式会社アクティバスファーマ |
医療用複合有機化合物粉体、その製造方法ならびに懸濁液
|
EP2168573A1
(de)
*
|
2008-09-30 |
2010-03-31 |
LEK Pharmaceuticals D.D. |
Zubereitungen enthaltend Ezetimib
|
BRPI1014278B8
(pt)
*
|
2009-04-24 |
2021-05-25 |
Iceutica Pty Ltd |
método para produzir uma forma de dosagem compreendendo metaxolona, forma de dosagem, composição farmacêutica compreendendo a referida forma de dosagem e uso da mesma
|
AP3629A
(en)
*
|
2009-04-24 |
2016-03-08 |
Iceutica Pty Ltd |
Method for improving the dissolution profile of a biologically active material
|
JP6222924B2
(ja)
|
2009-04-24 |
2017-11-01 |
イシューティカ ピーティーワイ リミテッド |
ジクロフェナクの新規製剤
|
MY159208A
(en)
*
|
2009-04-24 |
2016-12-30 |
Iceutica Pty Ltd |
A novel formulation of indomethacin
|
NZ595984A
(en)
*
|
2009-04-24 |
2014-04-30 |
Iceutica Pty Ltd |
Production of encapsulated nanoparticles at commercial scale
|
EA201171284A1
(ru)
*
|
2009-04-24 |
2012-05-30 |
Айсьютика Пти Лтд. |
Новая технология изготовления напроксена
|
MX344838B
(es)
*
|
2009-04-24 |
2017-01-09 |
Iceutica Pty Ltd |
Metodo para la produccion de polvos de nanoparticulas y microparticulas comerciales.
|
EP2484383B1
(de)
|
2009-09-30 |
2021-04-28 |
Kabushiki Kaisha Sangi |
Verfahren zur verbesserung der wasserlöslichkeit schlecht löslicher substanzen
|
ES2601884T3
(es)
|
2010-03-19 |
2017-02-16 |
Daiichi Sankyo Company, Limited |
Procedimiento para mejorar la capacidad de disolución de un anticoagulante
|
AU2011230144B2
(en)
|
2010-03-22 |
2015-01-22 |
Bio-Synectics Inc. |
Method for preparing nano-particles
|
CN102408756B
(zh)
*
|
2011-08-05 |
2013-06-19 |
中国人民解放军第四军医大学 |
DiI 显微颗粒简易制作及其标记神经元的方法
|
TWI578988B
(zh)
|
2011-08-10 |
2017-04-21 |
第一三共股份有限公司 |
含二胺衍生物之醫藥組成物
|
KR101794032B1
(ko)
|
2011-09-21 |
2017-11-07 |
(주)바이오시네틱스 |
나노입자 제조방법
|
JP5909796B2
(ja)
|
2012-03-02 |
2016-04-27 |
株式会社サンギ |
難溶性物質の水溶解性改善方法
|
KR102105354B1
(ko)
|
2012-08-20 |
2020-04-29 |
오츠카 세이야쿠 가부시키가이샤 |
당대사능의 측정 방법 및 그에 사용하는 조성물
|
EP2975400B1
(de)
|
2013-03-15 |
2019-09-04 |
Otsuka Pharmaceutical Co., Ltd. |
Zusammensetzung zur verwendung in einem verfahren zur messung des zucker- / fettsäureverbrennungsverhältnisses
|
US9526734B2
(en)
|
2014-06-09 |
2016-12-27 |
Iceutica Pty Ltd. |
Formulation of meloxicam
|
EP3466411A4
(de)
*
|
2016-05-31 |
2020-01-15 |
Kyowa Hakko Kirin Co., Ltd. |
Verfahren zur herstellung einer pharmazeutischen zusammensetzung mit mikropartikeln eines schwer löslichen arzneimittels
|
ES2813561T3
(es)
|
2017-09-07 |
2021-03-24 |
Tiefenbacher Alfred E Gmbh & Co Kg |
Composición farmacéutica en comprimido que comprende bilastina
|
ES2835287T3
(es)
|
2017-12-18 |
2021-06-22 |
Tiefenbacher Alfred E Gmbh & Co Kg |
Composición farmacéutica de comprimido que comprende la forma polimórfica 3 de bilastina y aluminometasilicato de magnesio
|
WO2020179025A1
(ja)
*
|
2019-03-06 |
2020-09-10 |
株式会社伊藤園 |
植物含有組成物の製造方法
|